by APFLI | Aug 30, 2006 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
On July 31, 2006, the U.S. Food and Drug Administration (FDA) announced that it was working with the manufacturer of the Plan B. "Morning after Pill," Duramed Research, Inc., to resolve the remaining policy issues preventing Plan B from being sold...
by APFLI | Mar 16, 2006 | Possible Adverse Effects
The Health Risks of Abortion by Mary Cunningham Agee "If only I had known." This is the haunting lament that I hear almost daily on the toll free crisis hotline of the Nurturing Network. Since founding this charitable organization almost twenty years...
by APFLI | Oct 4, 2005 | Studies - General Research
This report was written in 1994; the published sources range from the 1970s to the 1990s. Like other pages presented in this section which contain older studies, it is presented primarily to show how much abortion research has been available – but ignored...
by APFLI | Sep 19, 2005 | Possible Adverse Effects
People, historically, are known to accept as factual that which is not. If they hear something repeated often enough, and forcefully enough, many people tend to accept it at face value. In fact, that was a frequent comment of Hitler. Consequently, propaganda,...
by APFLI | Aug 24, 2005 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
Press Release, Friday, 26 August 05 The Food and Drug Administration (FDA) announced 26Aug05 that it needs public input to decide whether Plan B, the “morning-after pill,” can be sold both without a prescription for those aged 17 and over, yet require a...